台股 » 個股 » 智擎 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智擎

(4162)
可現股當沖
  • 股價
    90.3
  • 漲跌
    ▲0.4
  • 漲幅
    +0.44%
  • 成交量
    308
  • 產業
    上櫃 生技醫療類股
  • 310人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
智擎 (4162)籌碼相關-港商法國興業 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw06/2207/0607/2208/0208/1608/3009/1409/2810/1210/2611/0811/2212/0612/2001/0401/1802/0802/2203/0805/1805/2803/2004/0104/1404/2405/06708090100110Jul '24Sep '24Nov '24Jan '25Mar '25May '2560d90dAll

港商法國興業 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/05/279891.2300.0091.20989899.90%
2025/05/2600.002391.2791.10-231,106-2.08%
2025/05/2300.001792.7292.40-171,120-1.52%
2025/05/225492.1900.0092.50541,1434.72%
2025/05/21293.401492.6592.20-121,174-1.02%
2025/05/207992.4900.0092.40791,1826.68%
2025/05/153791.19891.2390.90291,2302.36%
2025/05/1400.002091.2691.60-201,258-1.59%
2025/05/1300.002489.9589.80-241,266-1.90%
2025/05/1200.001090.7790.60-101,298-0.77%
2025/05/0800.00488.0089.60-41,415-0.28%
2025/05/0700.001287.0887.70-121,473-0.81%
2025/04/2900.00790.7191.00-71,791-0.39%
2025/04/2800.006390.5590.50-631,790-3.52%
2025/04/1700.00788.0789.40-71,792-0.39%
2025/04/1600.00588.4287.10-51,817-0.28%
2025/04/1500.00486.9589.20-41,828-0.22%
2025/04/0800.0014781.8784.60-1471,801-8.16% 大賣/鉅額交易
2025/04/0200.00498.8898.80-41,770-0.23%
2025/04/0100.00797.9997.30-71,773-0.39%
2025/03/2800.008100.69100.50-81,752-0.46%
2025/03/2700.007104.00103.50-71,728-0.40%
2025/03/2600.007104.64104.50-71,723-0.41%
2025/03/2500.008105.00104.50-81,719-0.47%
2025/03/2013106.3500.00106.00131,7130.76%
2025/03/1420105.5000.00105.00201,7131.17%
2025/03/1326105.6900.00103.50261,7071.52%
2025/03/1224107.9200.00107.00241,6951.42%
2025/03/1000.0018106.50107.00-181,686-1.07%
2025/03/0700.0017107.00107.50-171,665-1.02%
2025/03/061114.0000.00111.0011,6470.06%
2025/03/0500.005114.40115.50-51,645-0.30%
2025/03/03148113.1000.00112.501481,6209.13% 大買/鉅額交易
2025/02/2752112.9100.00109.00521,5683.31%
2025/02/2500.0010113.50113.00-101,443-0.69%
2025/02/2400.0018115.00115.00-181,431-1.26%
2025/02/2000.0014110.57110.00-141,389-1.01%
2025/02/1862109.8900.00110.00621,4014.42%
2025/02/1700.0010113.00112.50-101,397-0.72%
2025/02/1400.0013111.04111.50-131,408-0.92%
2025/02/1294110.9100.00112.00941,4086.67%
2025/02/115110.9000.00109.0051,3920.36%
2025/02/1033118.9500.00118.50331,3372.47%
2025/02/0765119.0400.00120.50651,3514.81%
2025/02/0648119.5900.00119.00481,3293.61%
2025/02/0473102.2600.00103.00731,2016.08%
2024/12/02398.0000.0094.4031,1580.26%
2024/11/261094.1900.0094.00101,0840.92%
2024/11/211996.8700.0096.20191,0211.86%
2024/11/201997.0200.0096.50191,0181.87%
2024/11/1557100.5400.0099.90579895.76%
2024/11/1312106.7100.00106.50129461.27%
2024/08/2000.002085.6285.80-20742-2.69%
2024/08/0800.00686.1085.40-6799-0.75%
2024/08/072686.5800.0086.70267943.27%
2024/07/29595.3400.0094.5057360.68%
2024/07/262396.3900.0097.60237293.15%
〈焦點股〉智擎胰腺癌新藥展望正向 股價帶量衝高Anue鉅亨-2025/03/03
智擎胰腺癌新藥2024淨銷售額達標 5000萬美元授權金將入袋Anue鉅亨-2025/02/05
智擎 相關文章